期刊文献+

Isthmin对博来霉素诱导肺纤维化小鼠胶原沉积及血管生成的影响

Influence of Isthmin on collagen deposition and angiogenesis in mouse with bleomycin-induced pulmonary fibrosis
原文传递
导出
摘要 目的探讨Isthmin(ISM)对肺纤维模型小鼠肺部胶原沉积、血管新生的影响,为肺纤维化的防治提供理论依据。方法将昆明小鼠随机分成:对照组、模型组、ISM组3组,每组16只。博来霉素(BLM)气管内滴入制作小鼠肺纤维化模型,对照组(气管内注射0.9%NS+尾静脉注入0.9%NS)、模型组(气管内注射BLM+尾静脉注入0.9%NS)、ISM组(气管内注射BLM+尾静脉注入Isthmin蛋白)。分别于第7天、14天、21天、28天取实验小鼠肺组织,病理切片苏木精-伊红染色(HE)染色观察肺结构变化,Masson染色了解肺部胶原沉积情况,CD31免疫组化观察对血管内皮细胞数目的影响。结果给予ISM蛋白可减轻小鼠肺结构破坏,减少肺部胶原沉积,血管内皮细胞数目增加。肺组织胶原纤维Masson染色经平均光密度比较,模型组与对照组第7、14、21和28天差异具有统计学意义(P<0.01);Isthmin组与模型组比较,第21天和28天差异具有统计学意义(P<0.01);肺组织CD31蛋白平均光密度比较,模型组与对照组第14天、21天和28天差异显著(P<0.05)、第7天差异具有统计学意义(P<0.01),Isthmin组与模型组比较,第21天和28天差异具有统计学意义(P<0.05)。结论 ISM蛋白可减轻肺纤维化程度,但不是通过抑制血管形成实现的。 Objective To investigate the effect of Isthmin (ISM) on collagen deposition and angiogenesis in mouse with pulmonary fibrosis, and in order to provide the theory basis for the prevention of pulmonary fibrosis. Methods KM mice were randomly divided into 3 groups ( n = 16) : control group, model group, ISM group. The pulmonary fibrosis mouse model was produced by intratracheal instillation of bleomycin (BLM). The experimental mouse were injected recombinant ISM by tail vein. Control group (intratracheal instillation of 0.9% NS + tail vein of 0.9% NS), model group( intratracheal instillation of BLM + tail vein of 0.9% NS), ISM group (intratracheal instillation of BLM + tail vein of ISM). 7, 14, 21, 28 days after exposure, respectively, lung tissue of mouse were taken out for pathological observation : hematoxylin and eosin (HE) staining for changes in the structure of the lungs, Masson staining for lung collagen deposition, immunohistochemistry (determination of CD31 protein level ) for endothelial. Results ISM can reduce structural damage to the mouse lungs and lung collagen deposition, number of endothelial was increased. There was very statistically significant difference of the average optical density of lung tissue collagen fiber by Masson staining between model group and control group after 7, 14, 21 and 28 days ( P 〈 0. 01 ) ; Isthmin group compared with model group, it had very statistically significant difference after 21 and 28 days (P 〈 0.01 ). There was statistically significant difference of average optical density of lung tissue CD31 protein in model group and control group after 14 days, 21 days and 28 days(P 〈 0.05), very statistically significant difference after 7 days(P 〈 0.01 ) , Isthmin group compared with model group, there was statistically significant difference after 21 and 28 days (P 〈 0.05). Conclusions ISM can reduce pulmonary fibrosis, but it may not achieved by inhibiting angiogenesis.
出处 《中华肺部疾病杂志(电子版)》 CAS 2014年第1期12-15,共4页 Chinese Journal of Lung Diseases(Electronic Edition)
基金 国家自然科学基金(青年科学)项目(81000021)
关键词 肺纤维化 Isthmin 胶原沉积 血管形成 Pulmonary fibrosis Isthmin Collagen deposition Angiogenesis
  • 相关文献

参考文献15

  • 1Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management[J]. Am J Respir Crit Care Med, 2011, 183(6) : 788-824.
  • 2Tzortzaki EG, Antoniou KM, Zervou MI, et al. Effects of antifihrotic agents on TGF-betal, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis [ J]. Respir Med, 2007, 101 (8) : 1821-1829.
  • 3Farkas L, Gauldie J, Voelkel NF, et al. Pulmonary hypertension and idiopathic pulmonary fibrosis : a tale of angiogenesis, apoptosis, and growth factors[ J]. Am J Respir Cell Mol Biol, 2011, 45 (1) : 1-15.
  • 4Rossi V, Beffagna G, Rampazzo A, et al. TAIL1 : an isthmin-like gene, containing type 1 thrombospondin-repeat and AMOP domain, mapped to ARVD1 critical region[ J]. Gene, 2004, 335: 101-108.
  • 5Xiang W, Ke Z, Zhang Y, et al. Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in mice[ J]. J Cell Mol Med, 2011, 15(2): 359-374.
  • 6Moeller A, Ask K, Warburton D, et al. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis[J]. Int J Biochem Cell Biol, 2008, 40(3) : 362-382.
  • 7杨雪梅,王兴胜,崔社怀.NF-κB的诱捕寡核苷酸抑制肺纤维细胞Ⅰ型胶原mRNA表达的实验研究[J].免疫学杂志,2008,24(3):322-324. 被引量:4
  • 8张德平.对特发性肺纤维化诊治国际循证指南的理解与思考[J].中华肺部疾病杂志(电子版),2012,5(2):5-8. 被引量:9
  • 9张钰旋,李惠萍.端粒与特发性肺纤维化[J].中华肺部疾病杂志(电子版),2012,5(2):49-51. 被引量:1
  • 10文富强,胡倩婧.特发性肺纤维化的治疗展望[J].西部医学,2013,25(1):1-2. 被引量:9

二级参考文献24

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部